Product Description
Overall, the global vertebral compression fracture (VCF) market was valued at $1 billion in 2021. This is expected to increase over the forecast period at a CAGR of 5.1% to reach $1.4 billion.
Throughout this medical market research, we analyzed over 15 vertebral compression fracture companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for vertebral compression fracture devices extends its projections up to the year 2028, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2028, and Historical Data to 2018
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Vertebral Compression Fracture Market Insights
All regions are expected to see growth in the VCF market, but growth rates vary. Africa is projected to have the highest growth rate, followed by Central and Eastern Europe, and the Middle East. Western Europe has the lowest anticipated growth, with North America following closely. This difference is likely due to the more mature markets in North America and Western Europe, with North America having the largest VCF market, and Western Europe ranking third after Asia-Pacific, which has a higher population.
Global Vertebral Compression Fracture Market Share Insights
- In 2021, Medtronic held the dominant position in the global VCF market, commanding nearly half of the market share. The company emerged as the leader in most regions, with a particularly robust presence in North American and Western European markets contributing significantly to its leading position.
- Stryker secured the second position in the global VCF market in 2021. Offering a comprehensive vertebroplasty system, including the AutoPlex™ cement mixer, delivery system, and bone cements like VertaPlex™ and SpinePlex®, Stryker‘s success is attributed to its influence in the vertebroplasty market and the cost-effectiveness of its PVA system compared to competitors.
- Shanghai Kailitai Medical Group earned a spot among the top five global VCF market companies, leveraging its strong presence in China. The company’s portfolio includes bone cement and delivery systems, featuring a wire-controlled delivery system for remote physician control and an extension balloon catheter designed for vertebral decompression.
Market Segmentation Summary
- Vertebroplasty Market
- Percutaneous Vertebral Augmentation Market
Global Research Scope Summary
Report Attribute | Details |
---|---|
Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2021 |
Forecast | 2022-2028 |
Historical Data | 2018-2021 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |